BACKGROUND AND PURPOSE: Cholinesterase-inhibitor therapy is approved for treatment
of Alzheimer disease; however, application in patients with mild cognitive impairment (MCI) …

Objective Cholinesterase inhibitors improve cognitive functioning in Alzheimer disease (AD).
The authors studied, with functional magnetic resonance imaging (fMRI), the neural …

Neuroimaging studies of cholinesterase inhibitor (ChEI) treatment in Alzheimer's disease
(AD) have shown the different short and long term actions of ChEIs. fMRI studies of the ChEI …

Cholinesterase inhibitors positively affect cognition in Alzheimer's disease (AD) and other
conditions, but no controlled functional MRI studies have examined where their effects occur …

Previous studies with functional magnetic resonance imaging (fMRI) demonstrated a
differential brain activity and connectivity after treatment with donepezil in Alzheimer's …

A magnetic resonance imaging (MRI) study was conducted as part of an intervention study
in subjects with amnestic mild cognitive impairment (aMCI) to assess donepezil's treatment …

Abstract Background/Aims: Visuospatial impairments are known to occur in Alzheimer's
disease (AD). We hypothesised that functional magnetic resonance imaging (fMRI) …

We used functional connectivity magnetic resonance imaging (fcMRI) to investigate changes
in interhemispheric brain connectivity in 11 patients with mild Alzheimer's disease (AD) …

Cerebral blood flow (CBF) was assessed during a verbal recall task using [15O] water
positron emission tomography (PET) in older adults with mild cognitive deficits participating …

Background: Treatment of mild cognitive impairment (MCI) with cholinesterase inhibitors
may improve symptoms. Methods: In this multicenter, randomized, placebo-controlled trial …